ORIC Pharmaceuticals Operating Income

ORIC Pharmaceuticals (ORIC) currently reports a operating income of $-160M as of June 2026. That compares with $-150M in the prior-year period — down 4.3% year over year. Use the charts on this page to explore ORIC Pharmaceuticals's operating income history and peer comparisons.

ORIC Pharmaceuticals's operating income decreased from $-150M to $-160M — a 4.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ORIC Pharmaceuticals reported $-160M in operating income as of June 2026. That compares with $-150M in the prior-year period — down 4.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-160M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ORIC Pharmaceuticals, and consider following ORIC for alerts when major investors trade the stock.

ORIC Pharmaceuticals is classified in the Healthcare sector. On operating income, it currently shows $-160M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORIC with unrelated industries.